113 research outputs found
Topological Darkness: How to Design a Metamaterial for Optical Biosensing with Virtually Unlimited Sensitivity
Due to the absence of labels and fast analyses, optical biosensors promise
major advances in biomedical diagnostics, security, environmental and food
safety applications. However, sensitivity of the most advanced plasmonic
biosensor implementations has a fundamental limitation caused by losses in the
system and or geometry of biochips. Here, we report a scissor effect in
topologically dark metamaterials which is capable of providing virtually
unlimited bona fide sensitivity to biosensing thus solving the bottleneck
sensitivity limitation problem. We explain how the scissor effect can be
realized via a proper design of topologically dark metamaterials and describe
strategies for their fabrication. To validate the applicability of this effect
in biosensing, we demonstrate the detection of folic acid (vitamin important
for human health) in the wide 3-log linear dynamic range with the limit of
detection of 0.125 nM, which is orders of magnitude better than previously
reported for all optical counterparts. Our work opens possibilities for
designing and realising plasmonic, semiconductor and dielectric metamaterials
with ultra-sensitivity to binding events.Comment: 22 pages, 4 figure
Modelling of the receptor-ligand interaction in a single cell mode
Membrane-associated intrareceptoral and ligand-receptor interactions are involved in intracellular signalling. Community of surface receptors represents extremely important target for modern therapeutics. Their developing evidently requires elaboration of effective screening platforms. In this study we suggest universal platform designed to test receptor-ligand interaction in a "single cell" mode. For this purpose we created a DNA vector utilizing modular structure of chimeric receptors. The whole platform was tested using myc peptide - anti-myc antibody counterpart, which is directly linked with regulation of cancer cell development. In this study we succeeded to obtain Jurkat cells transduced with cDNA coding for chimeric antigenic receptor containing extracellular scFv of the myc-specific antibody and human Fc fused with transmembrane anchor. We showed that chimeric receptor interacts with myc peptide in a "single cell" mode, which in turn leads to the activation of T cells. We further suggest that designed system can be used for any other receptor-ligand pair to detect their interaction directly on the cell surface. Elaborated platform may be applied for the widerange screening of the agents with therapeutic potential on the cell membrane ex vivo
Force spectroscopy of barnase-barstar single molecule interaction
Results of the single molecule force spectroscopy study of specific interactions between ribonuclease barnase and its inhibitor barstar are presented. Experimental data obtained for the force loading rate ranging 2-70 nN/s are well approximated by a single straight line, from which the dissociation barrier of the width of 0.12 nm and height of 0.75-0.85X10(-19) J can be inferred. The measured value of specific interaction does not depend on the NaCl concentration. This apparently contradicts the well-known dependence of the binding energy of this pair on the salt concentration, but such a "contradiction" is explained by the insensitivity of the force spectroscopy data to the relatively long-range electrostatic interaction. The latter essentially contributes to the value of barnase-barstar binding energy revealed by biochemical measurements, and it is exactly this electrostatic interaction which is influenced by the salt concentration. Copyright (C) 2010 John Wiley & Sons, Ltd
Possibilities of radionuclide visualization of HER2/neu-positive breast cancer using a radiopharmaceutical based on recombinant targeting molecules DARPin9_29
Epidermal growth receptor HER2/neu is still of great interest, the overexpression of which is most often observed in patients with breast cancer and accounts for 15β20 % of cases. Present methods of HER2/neu determination have a number of significant drawbacks. In recent years, alternative framework proteins are used for the targeted radionuclide imaging. Molecules of DARPin (Design Ankyrin Repeat Protein) are one of representatives of scaffolds. Material and methods. The study included 4 breast cancer patients (T1-2N0-1M0) who were not receiving systemic therapy at the time of the study: in 2 patients, HER2/neu overexpression was noted, in 2 patients β not detected. HER2/neu status was determined using an immunohistochemical method and a FISH assay. At the preclinical stage, radiopharmaceutical 99mTc-DARPin9_29 was injected intravenously to all patients, Β«WholeBodyΒ» scintigraphy and single-photon emission computed tomography were performed 2 hours after injection. Results. The distribution of radiopharmaceuticals in organs 2 hours after injection revealed the greatest accumulation in the liver and kidneys. In studying of tumor/background indicator it was revealed that values of the studied parameter in patients with overexpression of HER2 receptors are more than 3 times higher than the values in the subgroup of patients with negative expression of this marker. Conclusion. According to the results of preliminary studies, the 99mTc-DARPin9_29 demonstrated significant differences between tumors with and without HER2/neu overexpression
Genetically engineered CD80βpMHC-harboring extracellular vesicles for antigen-specific CD4+ T-cell engagement
The identification of low-frequency antigen-specific CD4+ T cells is crucial for effective immunomonitoring across various diseases. However, this task still encounters experimental challenges necessitating the implementation of enrichment procedures. While existing antigen-specific expansion technologies predominantly concentrate on the enrichment of CD8+ T cells, advancements in methods targeting CD4+ T cells have been limited. In this study, we report a technique that harnesses antigen-presenting extracellular vesicles (EVs) for stimulation and expansion of antigen-specific CD4+ T cells. EVs are derived from a genetically modified HeLa cell line designed to emulate professional antigen-presenting cells (APCs) by expressing key costimulatory molecules CD80 and specific peptideβMHC-II complexes (pMHCs). Our results demonstrate the beneficial potent stimulatory capacity of EVs in activating both immortalized and isolated human CD4+ T cells from peripheral blood mononuclear cells (PBMCs). Our technique successfully expands low-frequency influenza-specific CD4+ T cells from healthy individuals. In summary, the elaborated methodology represents a streamlined and efficient approach for the detection and expansion of antigen-specific CD4+ T cells, presenting a valuable alternative to existing antigen-specific T-cell expansion protocols
ΠΠΎΠ²ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΠΎΠ³Π»Π°ΡΠΎΠ²Π°Π½Π½ΠΎΡΡΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΊΠΎΠΆΠ½ΠΎΠ³ΠΎ Π°Π»Π»Π΅ΡΠ³ΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΊ ΠΏΠΈΡΠ΅Π²ΡΠΌ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌ Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° Π ΠΈ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ ΠΏΠΈΡΠ΅Π²ΠΎΠΉ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ Π² ΡΠ½Π΄Π΅ΠΌΠΈΡΠ½ΡΡ ΠΏΠΎ ΠΎΠΏΠΈΡΡΠΎΡΡ ΠΎΠ·Ρ ΠΎΡΠ°Π³Π°Ρ
Aim: to investigate the consistency of skin prick-tests results with specific IgE level and symptoms of food allergy. The criteria of food allergy in children of opisthorchiasis endemic areas were developed: symptoms of food allergy within 2 hours, skin pricktests weal size β₯1 mm and (or) specific IgE β₯0,35 kUA/l.ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ Π°Π½Π°Π»ΠΈΠ· ΡΠΎΠ³Π»Π°ΡΠΎΠ²Π°Π½Π½ΠΎΡΡΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΊΠΎΠΆΠ½ΠΎΠ³ΠΎ Π°Π»Π»Π΅ΡΠ³ΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΊ ΠΏΠΈΡΠ΅Π²ΡΠΌ Π°Π»Π»Π΅ΡΠ³Π΅Π½Π°ΠΌ Ρ ΠΎΡΠ΅Π½ΠΊΠΎΠΉ ΡΡΠΎΠ²Π½Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° Π (IgE) ΠΈ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ ΠΏΠΈΡΠ΅Π²ΠΎΠΉ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ. ΠΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Ρ ΡΠ»Π΅Π΄ΡΡΡΠΈΠ΅ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π° ΠΏΠΈΡΠ΅Π²ΠΎΠΉ Π°Π»Π»Π΅ΡΠ³ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ, ΠΏΡΠΎΠΆΠΈΠ²Π°ΡΡΠΈΡ
Π² ΡΠ΅Π³ΠΈΠΎΠ½Π°Ρ
Ρ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡΡ ΠΎΠΏΠΈΡΡΠΎΡΡ
ΠΎΠ·Π°: Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ², Π²ΠΎΠ·Π½ΠΈΠΊΠ°ΡΡΠΈΡ
Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 2 Ρ ΠΏΠΎΡΠ»Π΅ ΡΠΏΠΎΡΡΠ΅Π±Π»Π΅Π½ΠΈΡ ΠΏΡΠΎΠ΄ΡΠΊΡΠ° ΠΏΠΈΡΠ°Π½ΠΈΡ, ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΊΠΎΠΆΠ½ΠΎΠ³ΠΎ Π°Π»Π»Π΅ΡΠ³ΠΎΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ β ΡΡΠ΅Π΄Π½ΠΈΠΉ Π΄ΠΈΠ°ΠΌΠ΅ΡΡ ΠΏΠ°ΠΏΡΠ»Ρ Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ 1 ΠΌΠΌ ΠΈ (ΠΈΠ»ΠΈ) ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ IgE ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²ΠΈ Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ 0,35 ΠΊΠΠ΄Π/Π»
ΠΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΡΡΠΆΠ΅ΡΡΠΈ ΠΈ Ρ ΡΠΎΠ½ΠΈΠ·Π°ΡΠΈΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈΠ· ΠΎΡΠ΄Π°Π»Π΅Π½Π½ΡΡ ΡΠ°ΠΉΠΎΠ½ΠΎΠ² Π’ΠΎΠΌΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ
The unified modeling language is used to design a structurally functional model of an information-analytical system for assessment of the state of a disease for the early detection of children with the increased risk of serious states living at sparsely populated territories. Using this model and methods of structured programming, as well as client-server technologies along with a structured query language, it is possible to develop a territorially distributed on-line system, which uses a common information space and accumulates centrally data on the severity of a disease.Π‘ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΡΠ·ΡΠΊΠ° ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΏΡΠΎΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½Π° ΡΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎ-Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Ρ ΡΠ΅Π»ΡΡ ΡΠ°Π½Π½Π΅Π³ΠΎ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΌ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΡΠΆΠ΅Π»ΡΡ
ΡΠΎΡΡΠΎΡΠ½ΠΈΠΉ, ΠΏΡΠΎΠΆΠΈΠ²Π°ΡΡΠΈΡ
Π½Π° ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΡΡ
Ρ ΠΌΠ°Π»ΠΎΠΉ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΡΡ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ. ΠΡΠ½ΠΎΠ²ΡΠ²Π°ΡΡΡ Π½Π° Π΄Π°Π½Π½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Π°Ρ
ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΠΊΠ»ΠΈΠ΅Π½Ρ-ΡΠ΅ΡΠ²Π΅ΡΠ½ΡΠ΅ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠΎΠ²ΠΌΠ΅ΡΡΠ½ΠΎ Ρ ΡΠ·ΡΠΊΠΎΠΌ ΡΡΡΡΠΊΡΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π·Π°ΠΏΡΠΎΡΠΎΠ² ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΠ΅Π°Π»ΠΈΠ·ΠΎΠ²Π°ΡΡ Π² ΡΠ΅Π°Π»ΡΠ½ΠΎΠΌ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎ ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΡΡ ΡΠΈΡΡΠ΅ΠΌΡ, ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡ Π΅Π΄ΠΈΠ½ΠΎΠ΅ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΏΡΠΎΡΡΡΠ°Π½ΡΡΠ²ΠΎ, ΡΠ΅Π½ΡΡΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎ Π½Π°ΠΊΠ°ΠΏΠ»ΠΈΠ²Π°ΡΡ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΡΠΆΠ΅ΡΡΠΈ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π±ΠΎΠ»Π΅Π·Π½ΠΈ
Tunable Growth Factor Delivery from Injectable Hydrogels for Tissue Engineering
Current sustained delivery strategies of protein therapeutics are limited by the fragility of the protein, resulting in minimal quantities of bioactive protein delivered. In order to achieve prolonged release of bioactive protein, an affinity-based approach was designed which exploits the specific binding of the Src homology 3 (SH3) domain with short proline-rich peptides. Specifically, methyl cellulose was modified with SH3-binding peptides (MC-peptide) with either a weak affinity or strong affinity for SH3. The release profile of SH3-rhFGF2 fusion protein from hyaluronan MC-SH3 peptide (HAMC-peptide) hydrogels was investigated and compared to unmodified controls. SH3-rhFGF2 release from HAMC-peptide was extended to 10 days using peptides with different binding affinities compared to the 48 h release from unmodified HAMC. This system is capable of delivering additional proteins with tunable rates of release, while maintaining bioactivity, and thus is broadly applicable
Π’Π΅ΡΡΠΈΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎ ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° Π΄ΠΈΡΠΏΠ°Π½ΡΠ΅ΡΠ½ΠΎΠ³ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΈ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π΄Π΅ΡΠ΅ΠΉ Ρ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²Π°ΠΌΠΈ, ΠΏΡΠΎΠΆΠΈΠ²Π°ΡΡΠΈΡ Π² ΠΎΡΠ΄Π°Π»Π΅Π½Π½ΡΡ ΡΠ°ΠΉΠΎΠ½Π°Ρ Π’ΠΎΠΌΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ
A unified simulation language has been used to develop the structurally functional model of the territorially distributed information system for follow-up care and monitoring of the health status of children with neurological disorders living in remote areas of the Tomsk Region. With this model and structured programming methods, client-server technologies along with the structured query language allow the development of the on-line information-analytical system, which uses the common information space and accumulates data on children with neurological disorders.Π‘ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΡΠ·ΡΠΊΠ° ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠΏΡΠΎΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½Π° ΡΡΡΡΠΊΡΡΡΠ½ΠΎ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΡΠ΅ΡΡΠΈΡΠΎΡΠΈΠ°Π»ΡΠ½ΠΎ ΡΠ°ΡΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π½ΠΎΠΉ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎ ΡΠΈΡΡΠ΅ΠΌΡ Π΄ΠΈΡΠΏΠ°Π½ΡΠ΅ΡΠ½ΠΎΠ³ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΠΈ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Π·Π΄ΠΎΡΠΎΠ²ΡΡ Π΄Π΅ΡΠ΅ΠΉ Ρ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²Π°ΠΌΠΈ, ΠΏΡΠΎΠΆΠΈΠ²Π°ΡΡΠΈΡ
Π² ΠΎΡΠ΄Π°Π»Π΅Π½Π½ΡΡ
ΡΠ°ΠΉΠΎΠ½Π°Ρ
Π’ΠΎΠΌΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ. ΠΡΠ½ΠΎΠ²ΡΠ²Π°ΡΡΡ Π½Π° Π΄Π°Π½Π½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΈ ΠΏΡΠΈΠΌΠ΅Π½ΡΡ ΠΌΠ΅ΡΠΎΠ΄Ρ ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΠΊΠ»ΠΈΠ΅Π½Ρ-ΡΠ΅ΡΠ²Π΅ΡΠ½ΡΠ΅ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠΎΠ²ΠΌΠ΅ΡΡΠ½ΠΎ Ρ ΡΠ·ΡΠΊΠΎΠΌ ΡΡΡΡΠΊΡΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π·Π°ΠΏΡΠΎΡΠΎΠ² ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΠ΅Π°Π»ΠΈΠ·ΠΎΠ²Π°ΡΡ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎ-Π°Π½Π°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΡΡ ΡΠΈΡΡΠ΅ΠΌΡ, Π² Β«ΡΠ΅Π°Π»ΡΠ½ΠΎΠΌ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈΒ» ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡ Π΅Π΄ΠΈΠ½ΠΎΠ΅ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΏΡΠΎΡΡΡΠ°Π½ΡΡΠ²ΠΎ, ΡΠ΅Π½ΡΡΠ°Π»ΠΈΠ·ΠΎΠ²Π°Π½Π½ΠΎ Π½Π°ΠΊΠ°ΠΏΠ»ΠΈΠ²Π°ΡΡ Π΄Π°Π½Π½ΡΠ΅ ΠΎ Π΄Π΅ΡΡΡ
Ρ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²Π°ΠΌΠΈ
- β¦